About ten years ago, scientists began exploring an unconventional idea for studying the brain: using bioluminescent light to ...

Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...

Artificial intelligence-supported cell imaging could help laboratories to set defensible quality thresholds for living ...

BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.

Ace Therapeutics recently launched in vivo efficacy testing services for IBD drug candidates. Ace Therapeutics, a preclinical ...

Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic ...

At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow cytometry has evolved from a specialist tool into a cornerstone ...

Global Research Antibodies and Reagents Market OverviewThe global research antibodies and reagents market is expected to expand at a CAGR of 7% between 2025 and 2030, driven by the rising need for ...

A research team has now decoded the function of two key apoptotic genes from fish—Fas-associated protein with death domain (FADD) and caspase-8 (caspase-8)—revealing their roles in cell death and ...

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 Pharmaceutical Technology Excellence Awards.

Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...